Publikation

Antibiotic treatment durations for common infectious diseases in Switzerland: comparison between real-life and local and international guideline recommendations.

Wissenschaftlicher Artikel/Review - 23.12.2022

Bereiche
PubMed
DOI
Kontakt

Zitation
Schaub C, Barnsteiner S, Schönenberg L, Bloch N, Dräger S, Albrich W, Conen A, Osthoff M. Antibiotic treatment durations for common infectious diseases in Switzerland: comparison between real-life and local and international guideline recommendations. J Glob Antimicrob Resist 2022; 32:11-17.
Art
Wissenschaftlicher Artikel/Review (Englisch)
Zeitschrift
J Glob Antimicrob Resist 2022; 32
Veröffentlichungsdatum
23.12.2022
eISSN (Online)
2213-7173
Seiten
11-17
Kurzbeschreibung/Zielsetzung

Shortening the duration of antibiotic therapy (DAT) for common infectious diseases may be an effective strategy to tackle antimicrobial resistance. Shorter DAT has been proven safe and effective for community-acquired pneumonia (CAP), cellulitis, and cholangitis.